These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24480636)

  • 41. Medication adherence and improved outcomes among patients with type 2 diabetes.
    Curtis SE; Boye KS; Lage MJ; Garcia-Perez LE
    Am J Manag Care; 2017 Jul; 23(7):e208-e214. PubMed ID: 28850793
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: a retrospective data analysis.
    Shenolikar RA; Balkrishnan R; Camacho FT; Whitmire JT; Anderson RT
    Clin Ther; 2006 Aug; 28(8):1199-1207. PubMed ID: 16982297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication Adherence and Diabetes Self-Care Activities Among Patients With Type 2 Diabetes Mellitus.
    Jannoo Z; Mamode Khan N
    Value Health Reg Issues; 2019 May; 18():30-35. PubMed ID: 30419448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A lifetime modelled economic evaluation comparing pioglitazone and rosiglitazone for the treatment of type 2 diabetes mellitus in the UK.
    Tilden DP; Mariz S; O'Bryan-Tear G; Bottomley J; Diamantopoulos A
    Pharmacoeconomics; 2007; 25(1):39-54. PubMed ID: 17192117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan.
    Horii T; Momo K; Yasu T; Kabeya Y; Atsuda K
    PLoS One; 2019; 14(10):e0223431. PubMed ID: 31593574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database.
    Kirkman MS; Rowan-Martin MT; Levin R; Fonseca VA; Schmittdiel JA; Herman WH; Aubert RE
    Diabetes Care; 2015 Apr; 38(4):604-9. PubMed ID: 25573883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between statin adherence and cholesterol level reduction from baseline in a veteran population.
    Kazerooni R; Watanabe JH; Bounthavong M
    Pharmacotherapy; 2013 Oct; 33(10):1044-52. PubMed ID: 23744794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Economic simulation of canagliflozin and sitagliptin treatment outcomes in patients with type 2 diabetes mellitus with inadequate glycemic control.
    Lafeuille MH; Grittner AM; Gravel J; Bailey RA; Martin S; Garber L; Duh MS; Lefebvre P
    J Med Econ; 2015 Feb; 18(2):113-25. PubMed ID: 25350645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adherence to multiple medications in the TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth) cohort: effect of additional medications on adherence to primary diabetes medication.
    Shah R; McKay SV; Levitt Katz LE; El Ghormli L; Anderson BJ; Casey TL; Higgins L; Izquierdo R; Wauters AD; Chang N;
    J Pediatr Endocrinol Metab; 2020 Feb; 33(2):191-198. PubMed ID: 31809265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and economic outcomes among injection-naïve patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study.
    Mody R; Huang Q; Yu M; Patel H; Zhang X; Wang L; Grabner M
    BMJ Open Diabetes Res Care; 2019; 7(1):e000884. PubMed ID: 31875137
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea.
    Lee WY; Ahn J; Kim JH; Hong YP; Hong SK; Kim YT; Lee SH; Morisky DE
    J Int Med Res; 2013 Aug; 41(4):1098-110. PubMed ID: 23860015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
    Morello CM; Rotunno T; Khoan J; Hirsch JD
    Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of rosiglitazone on serum lipoprotein(a) levels in Korean patients with type 2 diabetes mellitus.
    Ko SH; Song KH; Ahn YB; Yoo SJ; Son HS; Yoon KH; Cha BY; Lee KW; Son HY; Kang SK
    Metabolism; 2003 Jun; 52(6):731-4. PubMed ID: 12800099
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and Economic Outcomes of Patients with Type 2 Diabetes on Multiple Daily Injections of Basal-bolus Insulin (MDI) Therapy: A Retrospective Cohort Study.
    Brixner D; Ermakova A; Xiong Y; Sieradzan R; Sacks N; Cyr P; Taylor SD
    Clin Ther; 2019 Feb; 41(2):303-313.e1. PubMed ID: 30709610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.
    Ho PM; Rumsfeld JS; Masoudi FA; McClure DL; Plomondon ME; Steiner JF; Magid DJ
    Arch Intern Med; 2006 Sep; 166(17):1836-41. PubMed ID: 17000939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.
    Calip GS; Hubbard RA; Stergachis A; Malone KE; Gralow JR; Boudreau DM
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):75-85. PubMed ID: 24923811
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.
    Balkrishnan R; Rajagopalan R; Camacho FT; Huston SA; Murray FT; Anderson RT
    Clin Ther; 2003 Nov; 25(11):2958-71. PubMed ID: 14693318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors Associated with Poor Hemoglobin A1c Control in Patients with Type 2 Diabetes.
    Alqudah S; Jarab AS; Alefishat EA; Mayyas F; Khdour M; Pinto S
    Curr Diabetes Rev; 2019; 15(2):164-170. PubMed ID: 29745337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.